Revision history of "Preclinical and clinical development of innovative TrkB agonists in the treatment of nervous system diseases" (Q78893)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 March 2024

12 January 2024

14 June 2023

11 June 2023

24 May 2023

2 March 2023

25 October 2022

20 October 2022

25 July 2022

  • curprev 21:1621:16, 25 July 2022DG Regio talk contribs 86,029 bytes +55,536 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

15 January 2022

16 December 2021

7 December 2021

30 November 2021

  • curprev 14:2614:26, 30 November 2021DG Regio talk contribs 18,228 bytes +2,976 Created claim: summary (P836): Reference_Aid_programme: SA.41471(2015/X) But_public_aid: Article 25 du règlement (CE) no 651/2014 du 17 juin 2014 déclarant certaines catégories d’aides compatibles avec le marché intérieur en application des articles 107 et 108 du traité (JO URZ. EU L 187/1 du 26.6.2014). La dépression est l’état le plus courant du système nerveux central. L’utilisation d’antidépresseurs actuellement disponibles est limitée, car les effets thérapeutiques ne so...
  • curprev 14:2614:26, 30 November 2021DG Regio talk contribs 15,252 bytes +180 Changed label, description and/or aliases in fr: translated_label

29 October 2020

14 October 2020

  • curprev 10:3210:32, 14 October 2020DG Regio talk contribs 15,512 bytes +168 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 10:3210:32, 14 October 2020DG Regio talk contribs 15,344 bytes −181 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 10:3210:32, 14 October 2020DG Regio talk contribs 15,525 bytes +2,741 Created claim: summary (P836): Reference number of the aid programme: SA.41471(2015/X) Purpose of public aid: Article 25 of EC Regulation No 651/2014 of 17 June 2014 declaring certain types of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L. I'm sorry. EU L 187/1 of 26.06.2014). Depression is the most common central nervous system disorder. The use of currently available antidepressants is associated with certain restrict...
  • curprev 10:3210:32, 14 October 2020DG Regio talk contribs 12,784 bytes −2,310 Removed claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).Depression is the most common central nervous health condition.The use of currently available antidepressants is associated with certain limitations, since t...

15 July 2020

9 June 2020

6 June 2020

26 March 2020

4 March 2020

  • curprev 08:5308:53, 4 March 2020DG Regio talk contribs 13,372 bytes +2,310 Created claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).Depression is the most common central nervous health condition.The use of currently available antidepressants is associated with certain limitations, since the...

18 February 2020

8 February 2020

31 January 2020

13 January 2020